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Dicer and microRNAs protect adult dopamine neurons
Piotr Chmielarz1,2, Julia Konovalova1, Syeda Sadia Najam3, Heike Alter4, Timo Petteri Piepponen5, Holger Erfle6, Kai C Sonntag7,
Günther Schütz4, Ilya A Vinnikov*,3,4,8 and Andrii Domanskyi*,1,4,8
MicroRNAs (miRs) are important post-transcriptional regulators of gene expression implicated in neuronal development,
differentiation, aging and neurodegenerative diseases, including Parkinson’s disease (PD). Several miRs have been linked to PD-
associated genes, apoptosis and stress response pathways, suggesting that deregulation of miRs may contribute to the
development of the neurodegenerative phenotype. Here, we investigate the cell-autonomous role of miR processing RNAse Dicer
in the functional maintenance of adult dopamine (DA) neurons. We demonstrate a reduction of Dicer in the ventral midbrain and
altered miR expression profiles in laser-microdissected DA neurons of aged mice. Using a mouse line expressing tamoxifen-
inducible CreERT2 recombinase under control of the DA transporter promoter, we show that a tissue-specific conditional ablation
of Dicer in DA neurons of adult mice led to decreased levels of striatal DA and its metabolites without a reduction in neuronal body
numbers in hemizygous mice (DicerHET) and to progressive loss of DA neurons with severe locomotor deficits in nullizygous mice
(DicerCKO). Moreover, we show that pharmacological stimulation of miR biosynthesis promoted survival of cultured DA neurons
and reduced their vulnerability to thapsigargin-induced endoplasmic reticulum stress. Our data demonstrate that Dicer is crucial
for maintenance of adult DA neurons, whereas a stimulation of miR production can promote neuronal survival, which may have
direct implications for PD treatment.
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Dopamine (DA) neurons in the ventral midbrain project to
striatal, limbic and cortical areas forming neuronal networks
that regulate complex behaviors, emotions and controlled
voluntary motion.1 A progressive age-related degeneration of
mesostriatal DA neurons in the substantia nigra (SN) causes
motor symptoms in Parkinson’s disease (PD).2 Selective
vulnerability of DA neurons is attributed to number of factors,
including mitochondrial dysfunction, endoplasmic reticulum
(ER) stress, decreased neurotrophic factor signaling and
increased oxidative stress.3–5 The exact cause of SN DA cell
loss in sporadic PD is still unknown and the effectiveness of
current treatment approaches is limited. As aging remains the
strongest and most reliable risk factor in PD pathology,6 we
conducted in vivo studies in aging mice to further understand
the molecular mechanisms that contribute to the maintenance
of adult DA neurons in the SN.
MicroRNAs (miRs) are approximately 22 nucleotides long
non-coding RNAmolecules that bind to complementary sites in
target mRNAs and promote their degradation or suppress
translation.7 MiRs can mediate a formation of large-scale
regulatory networks and enable crosstalk between different
cellular pathways.8 They have crucial roles in neuronal cell
development and differentiation,9 and in the maintenance or
age-related degeneration of neuronal cell systems, including
DA neurons in PD.10–12MiR expression changeswere detected
in brain samples from PD patients, suggesting that particular
miRs can contribute to the development of the disease.13–17 As
PD strongly correlates with age, affecting about 1% of people
over 60 and 3% of people over 80 years,6 we hypothesized that
age-related changes in miR expression may be a contributing
factor to the selective vulnerability of DA neurons.
MiRs are processed from precursor molecules by two
protein complexes containing double-stranded RNA-specific
nucleases, Drosha and Dicer. Pri-miRs are initially cleaved in
the nucleus by a complex containing Drosha and DiGeorge
syndrome critical region gene 8 (DGCR8) proteins. In the
cytoplasm, pre-miRs are further cleaved by Dicer in a complex
with Argonaute 2 (Ago2), PACTand TARRNA-binding protein 2
(TRBP) to produce mature miRs, which direct RNA-induced
silencing complex to targetmRNAs.7,18,19 During aging, Dicer is
downregulated in the heart, adipose tissue and the brain.20,21
The age-related decline in its expression, possibly caused by
long-term cellular stress,22,23 results in diminished miR
processing and downregulation of mature miR levels.20,24
Accordingly, miR expression profiling revealed a predominant
decrease of miR levels in the aged mouse brain.25 Down-
regulation of mature miRs caused by dysfunction in miR
biogenesis pathways has also been observed inmotor neurons
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of amyotrophic lateral sclerosis (ALS) patients and in cells
exposed to ER or oxidative stress.18 Interestingly, enoxacin – a
small molecule interacting with TRBP and enhancing pre-miR
cleavage in the Dicer-PACT-TRBP-Ago2 protein complex19,26 –
corrected ALS-related defects in miR biogenesis in vitro, and
improved neuromuscular function in ALS mouse models.18
Disruption of the Dicer1 gene in embryonic DA neurons
severely impairs the development of the DA system.14 To
specifically study miR functions in adult DA neurons, we
generated a transgenic mouse model allowing conditional
ablation ofDicer1 using a tamoxifen (Tam)-inducible CreERT2
recombinase under control of the DA transporter (Dat, Slc6a3)
promoter.27–30 Compared with virus-mediated Cre expression
approaches,31 the robust Tam-inducible CreERT2 system
provides a high targeting efficiency and tight temporal and
spatial control over recombination. In this study, we analyzed
the cell-autonomous function of Dicer and the physiological
and pathophysiological roles of themiR biogenesis pathway in
adult DA neurons in the contexts of aging and PD. We show
that Dicer-dependent miRs are crucial for the maintenance of
adult DA neurons and that specific miRs are altered during
aging. We further show that pharmacological stimulation of
Dicer activity promoted survival of DA neurons in culture and
attenuated their vulnerability to ER stress.
Results
Dicer is downregulated in the ventral midbrain of aged
mice. Aging is the strongest risk factor in sporadic neurode-
generative diseases, including PD. We assessed the expres-
sion of Dicer1 and several other genes involved in the
Figure 1 Changes of mRNA and miR expression levels in the ventral midbrain and laser-microdissected DA neurons from young and old wild-type mice. (a) Selective
downregulation of Dicer1 mRNA in the ventral midbrain of aged wild-type mice (n= 6 and 8 for young and old animals, respectively). **Po0.01, as determined by Student’s
unpaired two-tailed t-test. (b-d) Comparison of mRNA levels for Th (DA neuron marker),Gfap (astrocyte marker) andGad2 (GABAergic neuron marker) in RNA preparations from
control ventral midbrain tissue (uncut) and laser-microdissected DA neurons (PALMed) (n= 5 and 6, respectively). ***Po0.001, as determined by Student’s unpaired two-tailed
t-test. (e) Heat maps showing expression levels, hierarchical clustering and fold change of 54 miRs with statistically significant changes (upregulated, red; downregulated, green;
Po0.05, as determined by Mann–Whitney test) in microdissected DA neurons comparing old with young mice (n= 5 and 7, respectively)
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development and physiology of DA neurons by analyzing
ventral midbrain samples from young (6.5 weeks) and old
(87 weeks) wild-type C57Bl/6 N mice. The expression of
typical DA neuronal genes and several members of neuron-
associated signaling pathways did not significantly change
with aging (Supplementary Figure S1A). In contrast, the
levels of Dicer1 mRNA were 20% downregulated in old
animals (Figure 1a). Interestingly, in our previous studies on
post-mortem laser-microdissected DA neurons, we observed
a reduction of DICER1 gene expression in PD patients (–1.9
fold, Po0.05) compared with age-matched healthy indivi-
duals, which was even more pronounced in the male
population (–2.7 fold, Po0.05).32
Predominant downregulation of miR expression levels in
aged DA neurons. To explore if the observed downregula-
tion of Dicer has led to changes in miR levels in aged DA
neurons, we utilized an established protocol combining
retrograde fluorescent-labeling with laser-assisted microdis-
section of DA neurons in young and aged mice.4 We first
assessed sample quality by determining the expression of
markers for DA neurons (tyrosine hydroxylase, Th), astro-
cytes (glial fibrillary acidic protein, Gfap) or GABAergic
neurons (glutamic acid decarboxylase 2, Gad2) on RNA
preparations isolated from the microdissected cells or
surrounding ventral midbrain tissue. Compared with the
latter, the relative amounts of Gfap and Gad2 transcripts
were depleted, whereas Th mRNA was markedly enriched in
the microdissected DA neuronal samples (Figures 1b-d).
These data confirm accurate microdissection and a high level
of enrichment of DA neurons. We then used high-throughput
TaqMan qPCR-based miR arrays that specifically detect the
mature forms of miRs,33 to assess miR expression profiles in
DA neurons from young and old C57Bl/6 N mice. This
profiling identified 54 significantly changed miRs, most of
which (42 miRs) being downregulated in the cells from old
animals (Figure 1e and Supplementary Table S1). Notably,
the expression levels of miR precursors remained unchanged
in old compared with young mice (Supplementary
Figure S1B), suggesting that the observed age-dependent
decline of mature miRs is not caused by attenuated
transcription of miR genes, but rather a consequence of
impaired miR processing.
Ablation of Dicer in adult DA neurons leads to their
progressive degeneration and loss of striatal DA. To
directly evaluate the importance of Dicer for the maintenance
of adult DA neurons, we generated Dicerfl/wt/DATCreERT2
mice (henceforth referred to as Dicer1 heterozygous condi-
tional knockout, DicerHET) and Dicerfl/fl/DATCreERT2 mice
(Dicer1 conditional knockout, DicerCKO), in which the essential
RNaseIII domain of the Dicer1 gene is flanked with LoxP
sites30 and the Tam-inducible CreERT2 recombinase is
expressed in DA neurons under control of the Dat
promoter.27 Induction of Cre recombination in 8- to 10-week-
old DicerHET mice by Tam injections resulted in a sex-specific
decrease of the levels of striatal DA and its metabolites 3,
4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid
Figure 2 Inducible deletion of one Dicer1 allele in adult DA neurons leads to decreased levels of striatal DA and its metabolites. (a-c) Quantification of striatal content of DA
and its derivatives DOPAC and HVA in control and DicerHET mice (males: n= 8 and 8, females: n= 5 and 4, respectively) 11 weeks after start of Tam injections. (d) Mean latency
to fall in a constant speed rotarod assay at 15, 25, 35 and 44 r.p.m. 90 weeks after start of Tam injections in control and DicerHET mice (n= 4 and 4, respectively). (e)
Immunostaining of the ventral midbrain sections from control and DicerHET mice 11 weeks after start of Tam injections. Scale bar, 500 μm. *Po0.05; **Po0.01; in comparison
with control mice, as determined by Student’s unpaired two-tailed t-test
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(HVA) as early as 11 weeks after recombination (Figures
2a-c). Notably, similar to the asymptomatic stages of PD, mild
decrease in DA levels upon gradual Dicer inactivation did not
cause movement/posture disturbances (Figure 2d). Moreover,
consistent with a male-directed bias in PD pathology,17,32 the
decreases in DA, DOPAC and HVA were significant in males,
whereas reaching only tendency levels in females 11 weeks
after Tam injections. Notably, at 19 weeks after recombination,
we observed a statistically significant decline in the levels of
striatal DA, but not DOPAC or HVA, in female DicerHET mice
compared with controls (Supplementary Figure S1C), how-
ever, this decrease was not as pronounced as in male
DicerHET mice at 11 weeks after Tam (Figure 2b). Importantly,
DicerHET mice exhibited no loss of DA neurons in the ventral
midbrain compared with age-matched controls (Figure 2e).
These data show that, similar to an age-related Dicer1
downregulation, its hemizygous inactivation causes functional
deficits in DA neurons below the threshold when locomotor
abnormalities become apparent.
In contrast, inactivation of both Dicer1 alleles resulted in a
selective loss of its expression in adult DA neurons already
2 weeks after the start of Tam treatment (Supplementary
Figure S1D). Dicer ablation led to a progressive loss of DA
neurons in the ventral midbrain and degeneration of their
axonal projections to the striatum (Figure 3). To confirm that
the observed reduction in neuronal cell numbers was indeed
caused by neurodegeneration and not by downregulation of
TH, we monitored the fate of DA neurons in Dicerfl/fl/tdTomato/
DATCreERT2mice that express fluorescent reporter tdTomato
upon Cre-mediated recombination selectively in DA neurons
(Supplementary Figure S2),34 and immunostained the ventral
midbrain sections with additional DA neuronal markers, such
as Dat and DA decarboxylase (Ddc). Similar to our observa-
tions on TH immunoreactivity (Figures 3a, b and Suppleme-
ntary Figure S3A), the number of neurons that were positive
for Dat, Ddc and tdTomato was markedly reduced in DicerCKO
animals (Figure 3c and Supplementary Figure S3B). Quanti-
fication revealed that DicerCKO mice lost about 90% of SN DA
neurons 10 weeks after Tam injections, whereas the VTA
region was more resistant to Dicer loss with some
TH-positive neurons remaining up to 8 months after Tam
treatment (Figures 3b, d, e and Supplementary Figure S3C).
This pattern of cell death is also seen in clinical PD further
corroborating a potential role of Dicer and miRs in PD
pathogenesis. The selective degeneration of DA neurons
was accompanied by a progressive loss of the striatal DA
content (Figure 3f).
In accordance with the dynamics of DA neuronal loss in the
SN and the VTA, DicerCKO mice exhibited elevated astro-
gliosis, as detected by increased anti-GFAP immunostaining
at 6 and 10 weeks after Tam treatment (Supplementary Figure
S4A-C). Increased oxidative stress is considered to be one of
the main factors involved in selective degeneration of DA
neurons in aging and PD.3 Consistently, after dihydroethidium
injection, we detected an increase in ethidium fluorescence in
TH-positive neurons of DicerCKO mice 4 weeks after Tam
treatment (Supplementary Figure S4D), indicative of elevated
mitochondrial ROS production.35 These data show that similar
to other animal models28 and PD patients,2 increased
oxidative stress also contributed to the degeneration of DA
neurons in DicerCKO mice.
DicerCKO mice exhibit progressive locomotor abnormal-
ities. As a consequence of the observed loss of the SN DA
neurons and striatal DA, DicerCKO mice exhibited progressive
balance and motor coordination abnormalities in a modified
constant speed rotarod assay, a highly sensitive method to
detect locomotor and balance deficits starting from the early
stages of neurodegeneration29,36 (Figure 4a). During the first
6 weeks after start of Tam treatment, all mice tested were
able to maintain their balance for 40–60 s at all rotation
speeds (Figure 4a). Starting from the 7th week, however,
DicerCKO mice exhibited a progressive decline in perfor-
mance that was initially detected at the highest rotation
speed, 44 rotations per minute (r.p.m.) and also gradually at
35, 25 and 15 r.p.m. during weeks 8 to 10 (Figure 4a). In the
12th week after Tam treatment, DicerCKO mice failed to
maintain balance at higher rotation speeds for 45 s
(Figure 4a). The mobility of DicerCKO mice in the open field
test was also greatly reduced at 10 weeks after Tam start
(Figures 4b, c and Supplementary Video S1). Notably, these
animals exhibited profound involuntary resting tremor, pos-
tural and gait impairments and rigidity (Supplementary
Videos S1 and S2), consistent with a characteristic complex
of PD symptoms.37 Similar to PD patients, treatment with
L-DOPA significantly improved the locomotor performance of
DicerCKO mice (Figure 4d), confirming that the observed
phenotype was due to the lack of DA input within the basal
ganglia circuit.
Stimulation of Dicer activity promotes survival of
cultured DA neurons. The observed neurodegenerative
phenotype of adult DicerCKO mice (Figure 3) demonstrates
the importance of the miR biogenesis pathway for the survival
of DA neurons. We therefore hypothesized that stimulation of
miR processing may promote DA neuronal maintenance and
evaluated the survival of DA neurons in mouse embryonic
midbrain cultures treated with enoxacin – a drug known to
stimulate Dicer activity.19 GDNF, a potent factor supporting DA
neuronal survival,5 was used as a positive control. After a 5-day
treatment with 50 μM enoxacin, we found an increase in the
number of surviving TH-positive DA neurons to similar levels as
observed with GDNF treatment (Figures 5a and b). Moreover,
similar to GDNF, enoxacin rescued DA neurons after thapsi-
gargin treatment (Figure 5c), but was not effective against
6OHDA and MPP+ (Supplementary Figure S5) at indicated
concentrations, suggesting that enoxacin specifically protected
DA neurons against ER stress. Thus, although knockout of
Dicer was fatal for DA neurons (Figure 3), activation of Dicer
and miR biogenesis was neuroprotective (Figure 5).
Discussion
Our results uncover an age-related downregulation of Dicer in
the ventral midbrain. We hypothesized that an age-related and
PD-linked decline of Dicer expressionmay cause deregulation
of miR networks and compromise the function of aged DA
neurons in a cell-autonomous manner. Indeed, mature miR
expression profiles in microdissected DA neurons from young
Dicer protects dopamine neurons
P Chmielarz et al
4
Cell Death and Disease
and old mice identified a number of deregulated miRs with
about 78% of them downregulated, whereas their precursors
remained unchanged in line with our hypothesis of impaired
Dicer-dependent miR maturation. Notably, comparison of our
miR expression profiles with deep sequencing data on whole
brain samples from aged mice25 revealed a strong overlap
between the two data sets (26 out of 42 downregulated miRs)
and strikingly similar expression changes of some of themiRs,
suggesting that these may regulate conserved pathways in
different neuronal cell populations.
Several miRs, such as miR-133b, miR-7 and miR-153,
miR-433, let-7a-5p and miR-184-5p, miR-205, miR-132 and
miR-34b/c, have previously been implicated in the
development and maintenance of DA neurons and were
linked to neurodegeneration.10,12,15,24 Although miR-133b
appeared to be important in the regulation of Pitx3 during
development of DA neurons,14 our data do not provide strong
support for its role in the maintenance of adult DA neurons, as
miR-133b had only a tendency to be downregulated in DA
neurons from old mice (P= 0.055). Expression levels of both
let-7a-5p and miR-184-5p in DA neurons from young or old
mice were low and remained unchanged. These data suggest
that, although these two miRs may promote survival of DA
neurons on the background of pathogenic mutations of
LRRK2 in transgenic flies,38 the normal aging process in
mammals does not seem to destabilize their expression.
Figure 3 Progressive degeneration of adult DA neurons after inducible ablation of both Dicer1 alleles. (a-c) Loss of the ventral midbrain DA neurons and their striatal
projections at indicated times after the induction of Dicer1 deletion by Tam injections (wpT, weeks post Tam) visualized by TH immunostaining or transgenic tdTomato
fluorescence. Scale bar, 500 μm. (d and e) Counts of TH-positive neurons in the SN (d) and ventral tegmental area (VTA) (e) in control and DicerCKO mice at indicated time points
after start of Tam injections (for control and DicerCKO mice: n= 7 and 9, 4 and 2, 8 and 6, 4 and 3, 4 and 3, respectively, for the indicated time points). (f) Quantification of striatal
DA content for control and DicerCKO mice: n= 5 and 4, 4 and 6, 6 and 8, 7 and 11, 12 and 18, respectively, for the indicated time points. *Po0.05; **Po0.01; ***Po0.001 in
comparison with control mice, as determined by Student’s unpaired two-tailed t-test. wk, week
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Among the miRs reported to regulate α-synuclein, miR-7a-5p
did not change and miR-153-3p was upregulated in DA
neurons from old mice, however, there was no evidence for a
reduction of Snca expression (Supplementary Figure S1A).
Our data indicate that the loss of Dicer function affects DA
neuronal survival. First, already a heterozygous ablation of
Dicer in adult DA neurons resulted in a progressive loss of
striatal DA and its metabolites, with apparent differential
vulnerability of male versus female mice Importantly, DICER1
appears to also be downregulated in DA neurons from PD
patients,32,39 implying that the age-related decline of Dicer
function could represent a mechanism contributing to
pathogenesis of PD. Similarly, heterozygous mutations of Dicer
have been implicated in cancer development40 demonstrating
that Dicer haploinsufficiency can affect cellular functions. We
further show that Dicer is crucially important for neuronal
survival, as its homozygous ablation caused degeneration of
DA neurons leading to a typical complex of PD-like symptoms,
which could be significantly alleviated by L-DOPA application.
Second, stimulation of Dicer activity with enoxacin19,26
promoted survival of cultured embryonic midbrain DA neurons
and rescued them from thapsigargin-induced death. In
contrast, enoxacin was not effective in protecting DA neurons
against 6OHDA and MPP+ at indicated concentrations
suggesting its specific activity in counteracting ER stress.
This finding is consistent with a protective activity of enoxacin
in stress-induced ALS-mutant HEK293 cells and in a mouse
model of ALS,18 suggesting that a stimulation of miR
Figure 4 Progressive locomotor abnormalities in DicerCKO mice. (a) Mean latency to fall in a constant speed rotarod assay at 15, 25, 35 and 44 r.p.m. at indicated times after
start of Tam injections in control and DicerCKO mice (n= 7 and 9, respectively). Automated threshold determination for each speed was followed by a log-rank test to calculate the
indicated P values. (b and c) Quantification (b) and representative animal tracks (c) of the total distance traveled by control or DicerCKO mice during 5-min open field tests
performed 10 weeks after start of Tam injections (n= 4 and 3, respectively). *Po0.05 as determined by Student’s unpaired two-tailed t-test. (d) Injection of L-DOPA attenuated
locomotor abnormalities in DicerCKO mice at 17 weeks after start of Tam injections measured by a constant speed rotarod assay at 15, 25, 35 and 44 r.p.m. (n= 5 and 4 for control
and DicerCKO mice, respectively). The indicated P-value was calculated by a two-way repeated measurements ANOVA
Dicer protects dopamine neurons
P Chmielarz et al
6
Cell Death and Disease
biogenesis may have general cytoprotective effects on the
background of ER stress. Thapsigargin treatment induces ER
stress and inhibits Dicer activity by promoting its localization to
stress granules.18 Interestingly, increased ER stress and
deregulation of unfolded protein response (UPR) pathways
may also promote age-related decline of DA neurons in PD.5
Regulation of ER stress and UPR pathways has been
suggested as a possible molecular mechanism of neuropro-
tection by neurotrophic factors CDNF and MANF promoting
survival of DA neurons in vitro and in vivo,41,42 whereas miRs
are also known to regulate neurotrophic factors signaling and
ER stress.43 In line with the enoxacin-mediated neuroprotec-
tion demonstrated in this study (Figures 5a-c), we speculate
that, similar to the mechanism proposed for ALS,23 the age-
related decline of Dicer combined with increased cellular
stress in DA neurons may compromise miR biogenesis thus
contributing to neurodegeneration in PD. Taken together, our
data suggest that disruption of miR biosynthesis in DA
neurons through Dicer downregulation or depletion profoundly
diminishes DA cell function and survival, whereas its
pharmacological stimulation is neuroprotective.
Materials and Methods
Animal experiments. Mice were maintained on the C57Bl/6 N genetic
background with a 12- h light–dark cycle and free access to water and food. The
Dicerfl/fl/DATCreERT2 (DicerCKO) and DicerHET mouse lines were generated by mating
Dicerfl/fl or Dicerfl/wt mice30 with DATCreERT2 mice.27 To generate Dicerfl/fl/tdTomato/
DATCreERT2 mice, Dicerfl/fl/DATCreERT2 animals were mated with Cre-reporter
Rosa26-tdTomato mice.34 Inducible Cre recombinase was activated in 8- to 10-week-
old mice by intraperitonial injections of 1 mg Tam (Sigma-Aldrich, St. Louis, MO, USA)
diluted in sunflower oil twice daily for 5 consecutive days.29,44 Littermates harboring
only floxed alleles were used as controls. All experimental procedures were performed
with the approval by the institutional Committee on Ethics of Animal Experimentation
(Regierungspräsidium Karlsruhe and national Animal Experiment Board of Finland)
and carried out in accordance with the local and European legislation on the protection
of animals used for scientific purposes.
Immunohistochemistry and fluorescent in situ hybridization
(FISH). Mice were perfused with 4% paraformaldehyde (PFA); the brains
dissected and fixed overnight in 4% PFA and processed for either paraffin or
vibratome sections. For cryosections, mice were killed, the brains dissected and
immediately frozen on dry ice. Immunohistochemical staining was performed as
previously described28,29 using the following antibodies: anti-TH (1:1000, Millipore,
Billerica, MA, USA, #AB1542), anti-DOPA decarboxylase (Ddc) (1:1000, Millipore
#AB1569), anti-dopamine transporter (Dat) (1:500, Millipore #MAB369) and anti-
glial fibrillary acidic protein (GFAP) (1:1000, Millipore #AB5541).
Combined FISH and immunofluorescence staining was performed either on
vibratome sections or on cryosections as described in.45 Briefly, brain sections were
incubated for 30 min at room temperature in 2 × SSC followed by prehybridization for
2 h in hybridization solution containing 50% deionized formamide (Ambion, Foster
City, CA, USA), 5 × SSC, 1 × Denhardt’s solution (Applichem, Darmstadt, Germany),
0.25 mg/ml yeast tRNA (Sigma-Aldrich) and 0.5 mg/ml salmon sperm DNA (Sigma-
Aldrich), and hybridized overnight at 55° C with 30 nM Dicer1-specific 5′- and 3′-DIG-
labeled miRCURY LNA detection probe (Exiqon, Vedbaek, Denmark) diluted in
hybridization solution. After stringency washes in the solution containing 50%
deionized formamide, 1 × SSC, and 0.1% Tween20, sections were washed in 0.2 ×
SSC and then in 1 × PBS containing 0.1% Tween20, and immunostained with anti-TH
antibody (1:500, Cell Signaling, Danvers, MA, USA #2792). The LNA probe was
detected with an anti-DIG-POD antibody (1:100, Roche, Indianapolis, IN, USA,
#11207733910) and visualized with TSA Plus Cy3 kit (PerkinElmer, Waltham,
MA, USA).
Quantitative RT-PCR. Total RNA isolated from ventral midbrain samples served
as a template for DNA synthesis using Super-Script III first-strand synthesis kit (Invitrogen,
Carlsbad, CA, USA). For genomic DNA contamination control, samples with no added
reverse transcriptase enzyme were included. Quantitative PCR was performed with a
CFX96 Real-Time System (Bio-Rad, Hercules, CA, USA) using TaqMan Gene
Expression Assays (Life Technologies, Carlsbad, CA, USA) according to the
manufacturer’s instructions. The mRNA levels of two housekeeping genes, Hprt1 and
B2m, were measured to control for the equal amount of input cDNA.
Figure 5 Stimulation of miR biogenesis pathway promotes survival of cultured DA neurons and protects them from thapsigargin-induced ER stress. (a and b) Counts of
TH-positive neurons (a) and representative TH immunostaining images (b) of primary ventral midbrain cultures from E13.5 mouse embryos after 5 days incubation in cell culture
medium supplemented with indicated concentrations of either GDNF, enoxacin or vehicle (n= 7–10). (c) Effect of GDNF and enoxacin on survival of primary ventral midbrain DA
neurons treated for 48 h (starting from day 5 in vitro) with ER stress inducer thapsigargin (TG) at indicated concentrations. GDNFand enoxacin were added to the cells 6 h prior to
TG treatment (n= 4–6). *Po0.05, **Po0.01 ***Po0.001, as determined by one-way ANOVA followed by Dunnett’s post hoc test (a) or Holm-Šídák test (c)
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Fluorescent labeling and laser microdissection of DA neurons in
mice. For retrograde labeling of DA neurons, mice were anesthetized with
ketamine/xylazin, placed in a stereotaxic frame (David Kopf Instruments, Tujunga,
CA, USA), and received instrastriatal (bregma +0.4 mm; lateral +/–1.8 mm; ventral –
3.5 mm) injections of 300 nl red fluorescent retrobeads (Lumafluor, Naples, FL,
USA). Animals were killed after 1–2 weeks, the brains dissected and used for
cryosectioning. Serial coronal sections (7 μm) of the midbrain spanning the region
between bregma –3.4 to –3.6 were mounted on nuclease-free membrane slides
(Zeiss, Oberkochen, Germany), fixed in ascending ethanol series and used for
laser-assisted microdissection of fluorescently labeled DA neurons in the SN from
both sides on the brain as described in.4 Individual neurons (approximately 2000
per mouse) were dissected on a Zeiss PALM MicroBeam system (Zeiss) and
catapulted into AdhesiveCap tubes (Zeiss). Total RNA including miRs was isolated
from the dissected samples with a miRNeasy Micro kit (Qiagen, Hilden, Germany),
according to the manufacturer’s instructions.
MiR expression profiling on DA neurons from young and old
mice. High-throughput miR expression profiling was performed using quantitative PCR
(qPCR)-based TaqMan miRNA arrays (Applied Biosystems, Foster City CA, USA)
according to the manufacturer’s instructions. Briefly, total RNA including miR isolated from
the microdissected DA neurons of seven young (10 weeks old) and five old (94 weeks
old) mice served as template for cDNA synthesis using Megaplex RT Primer pools A and
B. After 12 cycles of pre-amplification PCR with Megaplex PreAmp Primers, 40 cycles of
qPCR amplification were performed on TaqMan Array Rodent MicroRNA A and B Cards
Set v3.0 using 7900HT Fast Real-Time PCR System (Applied Biosystems).
Analysis of miR profiling data. Amplification plots were analyzed using
SDS2.2 software (Applied Biosystems) with Automatic Baseline and Manual Cq set to
0.2, as recommended by the manufacturer. Cq values were exported to qBase+
software (Biogazelle, Zwijnaarde, Belgium). Global normalization on all detected
targets46–48 was performed to calculate relative expression levels for every detected
miR, and statistically significant differences between young and old groups were
determined by Mann–Whitney test. Histograms and clustering were produced using
open source R/Bioconductor packages for the analysis of high-throughput qPCR.49,50
Quantification of miR precursors. MiR precursor molecules (pri-miR and
pre-miR) were quantified using miScript Precursor Assays (Qiagen) according to the
manufacturer’s instructions. The same total RNA samples used for mature miR
expression profiling served as templates for cDNA synthesis with miScript II RT Kit
(Qiagen, Hilden, Germany), using HiFlex buffer for the reaction. For genomic DNA
contamination control, samples with no added reverse transcriptase enzyme were
included. Quantitative PCR was performed on LightCycler 480 system (Roche,
Indianapolis, IN, USA) using QuantiTect SYBR Green PCR Master Mix and miScript
Precursor Assay primers targeting stem loops of selected miRs. snRNA RNU6B
was used for normalization.
Behavioral assays and L-DOPA treatment. The modified constant
speed rotarod assay was performed as previously described.29,36 After a training
period when each mouse attained stable baseline levels of performance staying at
15 r.p.m. for 60 s, mice received several trials at 15, 25, 35 and 44 r.p.m. rotation
speed with 60-s maximum trial length and 5-min intervals between individual trials.
Two maximal values per speed per day were used to calculate the average, which
was used for subsequent statistical analyses.
For the open field test, mice were placed individually into an open arena and
monitored for 5 min via video camera. The resulting data were analyzed using the
image processing system EthoVision 3.0 (Noldus Information Technology,
Wageningen, Netherlands) and Any-maze 4.82 (Stoelting Co., Wood Dale, IL,
USA). For each sample, the system recorded position, object area and the status of
defined events to calculate the traveled distance.
To follow the effects of L-3,4-dihydroxyphenylalanine (L-DOPA) on locomotor
performance, 17 weeks post Tam (wpT) injection control and Dicerfl/fl/DATCreERT2
mice were tested in the modified rotarod assay before and immediately after an
intraperitoneal injection of 20 mg/kg L-DOPA (Sigma-Aldrich) complemented with
12 mg/kg benserazide (Sigma-Aldrich).
In vivo detection of reactive oxygen species (ROS). To detect and
quantify the production of ROS, 200 μl dihydroethidium (Sigma-Aldrich; 1 mg/ml
solution) was administered via the tail vein injection51 to 4 weeks post-Tam Dicerfl/fl/
DATCreERT2 mice and controls as described in Andrews et al.35 The mice were killed
3.5 h after injection; brains were dissected, fixed overnight in 4% PFA, processed for
vibratome sections and immunostained with anti-TH antibody (Millipore). Ethidium
fluorescence was visualized using a Zeiss LSM780 confocal microscope.
Primary embryonic midbrain cultures and enoxacin treatment.
Primary cultures of mouse embryonic DA neurons were prepared as previously
described;52 the cells were plated in 10 μl drop of medium on poly-ornithine coated
wells of 96-well plates, and 1 h later 100 μl medium containing either vehicle, GDNF
(PeproTech, Rocky Hill, NJ, USA, 100 ng/μl), or enoxacin (Sigma-Aldrich; 25 or
50 μM) were added to each well. Forty-eight hours after plating, half of the medium
was replaced with the fresh one containing the same drug concentrations. The cells
were fixed 5 days after plating and DA neurons were identified by immunofluorescent
staining with anti-TH antibody (1:500; Millipore #MAB318). The plates were imaged
with CellInsight CX5 High Content Screening (HCS) Platform (Thermo Fisher
Scientific, Inc., Waltham, MA, USA) at × 10 magnification, and the images quantified
with CellProfiler software.53,54 Number of counted TH-positive cells was normalized to
a number of plated TH-positive cells (counted on the day 1 in vitro). The data
represent an average of 7–11 wells from two independent experiments.
To assess if enoxacin can rescue oxidative or ER stress-induced cell death, DA
cultures were prepared as described above, however, they were not treated with any
drugs until DIV5. At DIV5, half of the medium was replaced by the medium containing
GDNF (PeproTech, 100 ng/μl) or enoxacin (Sigma; 50 μM); 6 h later thapsigargin
(Thermo Fisher), 6OHDA (Sigma) or MPP+ (Sigma) were added to respective wells. Cells
were subsequently cultured for 24 h (6OHDA) or 48 h (thapsigargin and MPP+), fixed,
stained and counted as described above. Number of TH-positive cells was normalized to
control wells at the day of fixation. The data represent an average of 4–6 wells.
Statistical analysis. Statistical significance was calculated by Student’s two-tailed
unpaired t-test, Mann–Whitney test, one-way ANOVA followed by Dunnett’s multiple
comparison test, two-way ANOVA followed by Bonferroni post hoc test or log-rank test
using R/Bioconductor packages, qBase+ (Biogazelle) or GraphPad Prism software
(GraphPad Software, Inc., La Jolla, CA, USA). Data in text and figures are represented as
means ± S.E.M.
For the data from constant speed rotarod assays, we utilized Kaplan–Meier survival
analysis after automated threshold determination. As the time the mice could spend on
the rod was capped at a maximum of 60 s, the raw time values are of limited information
for statistical analysis. We therefore focused on the time period until a relevant decrease
in rotarod performance for each mouse could be observed and utilized Kaplan–Meier
survival analysis after automated threshold determination. As such, we took the first
time point when the time on the rod dropped below a specific threshold value. This
threshold value was determined for each rotarod speed in each animal experiment.
Healthy trained mice corrected for falls not related to locomotor performance, are able to
stay on the rod for 60 s at 15, 25 or 35 r.p.m. and450% of them fulfill this task also at
44 r.p.m.29,36 Therefore, the threshold value was defined as a mean between the
maximum time on the rod (60 s) and the mean time on the rod at the last time point
tested (12 weeks after Tam) for all animals in the DicerCKO group. As such data match
survival data in type, log-rank tests were used for analysis and calculation of P-values.
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